Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tembotrione SCHEMBL169887 | 0.86 | — | — | |
| Fenoxaprop-P-Ethyl SCHEMBL3232270 | 0.84 | TDP1 (0.36) | TP53MAPT | |
| Fenoxaprop-Ethyl SCHEMBL1100969 | 0.84 | TDP1 (0.36) | TP53MAPT | |
| Ethoxysulfuron SCHEMBL3233114 | 0.83 | TP53 (0.39) | TP53MAPT | |
| Fenoxaprop-P-Ethyl SCHEMBL2373488 | 0.79 | GAA (0.37) | TP53MAPT | |
| Tembotrione SCHEMBL170314 | 0.76 | — | — | |
| Tembotrione SCHEMBL169804 | 0.76 | — | — | |
| Ethoxysulfuron SCHEMBL170413 | 0.74 | — | — | |
| Ethoxysulfuron SCHEMBL169998 | 0.74 | — | — | |
| Fenoxaprop SCHEMBL19463635 | 0.70 | GAA (0.37) | TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234227-A1 | MICROEMULSION CONCENTRATES | BAYER CROPSCIENCE AG (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100048516-A1 | PENETRATION ENHANCER FOR FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-02-25 | — | — | US | disclosed |
| US-20080176746-A1 | avoids antagonistically reduced activity or overdosage otherwise requiring split applications; by employing an oil suspension concentrate | BAYER CROPSCIENCE AG (DE) | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048516-A1 | PENETRATION ENHANCER FOR FUNGICIDES | DDT, DCPS, TYMP | TP53 3879/4885MAPT 3917/4885 |
| US-20080176746-A1 | avoids antagonistically reduced activity or overdosage otherwise requiring split applications; by employing an oil suspension concentrate | LIPA, MGLL, ABHD6 | TP53 1768/4885MAPT 3201/4885 |
| US-20100234227-A1 | MICROEMULSION CONCENTRATES | ADH1C, MGLL, ADH1A | TP53 3756/4885MAPT 2722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.